1. Home
  2. CWT vs SUPN Comparison

CWT vs SUPN Comparison

Compare CWT & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo California Water Service Group

CWT

California Water Service Group

HOLD

Current Price

$44.60

Market Cap

2.8B

Sector

Utilities

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$44.31

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CWT
SUPN
Founded
1926
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Water Supply
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.6B
IPO Year
N/A
2012

Fundamental Metrics

Financial Performance
Metric
CWT
SUPN
Price
$44.60
$44.31
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$54.50
$63.25
AVG Volume (30 Days)
369.2K
1.0M
Earning Date
10-30-2025
11-04-2025
Dividend Yield
2.68%
N/A
EPS Growth
N/A
N/A
EPS
2.29
N/A
Revenue
$1,002,357,000.00
$681,539,000.00
Revenue This Year
N/A
$8.29
Revenue Next Year
$7.38
$22.72
P/E Ratio
$19.53
N/A
Revenue Growth
N/A
4.54
52 Week Low
$41.64
$29.16
52 Week High
$51.63
$57.65

Technical Indicators

Market Signals
Indicator
CWT
SUPN
Relative Strength Index (RSI) 41.50 38.66
Support Level $43.94 $44.37
Resistance Level $46.32 $47.00
Average True Range (ATR) 0.92 1.39
MACD -0.01 -0.06
Stochastic Oscillator 28.91 10.85

Price Performance

Historical Comparison
CWT
SUPN

About CWT California Water Service Group

California Water Service Group is a U.S. water and utilities holding company based in California. The company engages in the production, treatment, storage, distribution, and sale of water for various uses. The firm operates through its subsidiaries, which can be divided between regulated and unregulated businesses. The regulated public utilities subsidiaries operate in California, New Mexico, Washington, and Hawaii. The unregulated subsidiaries provide water utility services to private companies and municipalities. The company derives the majority of its revenue from its operations in California and, overall, from residential customers.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: